Mitsuhiro Takenoyama
- Oncology top 1%
- Lung Cancer Research Studies 40
- Cancer Immunotherapy and Biomarkers 27
-
- Lung Cancer Treatments and Mutations 82
- Lung Cancer Diagnosis and Treatment 57
- Pleural and Pulmonary Diseases 13
- Immunology top 2%
- Immunotherapy and Immune Responses 47
- Immune Cell Function and Interaction 34
- T-cell and B-cell Immunology 21
- Microbiology top 5%
- Cancer Research top 5%
Mitsuhiro Takenoyama
213 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 107
- Oncology 2.2k
- Pulmonary and Respiratory Medicine 1.9k
- Immunology 1.1k
- Microbiology 20
- Cancer Research 374
Countries citing papers authored by Mitsuhiro Takenoyama
This map shows the geographic impact of Mitsuhiro Takenoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuhiro Takenoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuhiro Takenoyama more than expected).
Fields of papers citing papers by Mitsuhiro Takenoyama
This network shows the impact of papers produced by Mitsuhiro Takenoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuhiro Takenoyama. The network helps show where Mitsuhiro Takenoyama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mitsuhiro Takenoyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 9 | |
| 4 | Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma | 2020 | 1 |
| 5 | 2019 | 124 | |
| 6 | 2018 | 8 | |
| 7 | 2018 | 5 | |
| 8 | 2017 | 10 | |
| 9 | 2017 | 26 | |
| 10 | 2014 | 32 | |
| 11 | 2013 | 3 | |
| 12 | 2013 | 31 | |
| 13 | 2011 | 2 | |
| 14 | 2011 | 2 | |
| 15 | 2011 | 0 | |
| 16 | 2007 | 1 | |
| 17 | 2004 | 14 | |
| 18 | 2002 | 55 | |
| 19 | 2001 | 14 | |
| 20 | 2000 | 25 |
About Mitsuhiro Takenoyama
Mitsuhiro Takenoyama is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 221 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (82 papers), Lung Cancer Diagnosis and Treatment (57 papers), Immunotherapy and Immune Responses (47 papers), Lung Cancer Research Studies (40 papers), Immune Cell Function and Interaction (34 papers), Cancer Immunotherapy and Biomarkers (27 papers), T-cell and B-cell Immunology (21 papers) and Pleural and Pulmonary Diseases (13 papers). The work is most often cited by research in Oncology (2.2k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Immunology (1.1k citations). Mitsuhiro Takenoyama has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Kosei Yasumoto, Takeshi Hanagiri, Kenji Sugio, Manabu Yasuda, Masakazu Sugaya, Takashi Seto, Yoshinobu Ichiki, Hidetaka Uramoto, Tomoko So and Yukito Ichinose. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Journal of Clinical Oncology, The Annals of Thoracic Surgery and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.